Statistics for Bristol-Myers Squibb (id:8499 BMY)

Valuation metrics

Market cap

114.02B

Enterprise value

157.43B

Trailing P/E (ttm)

11.54

Forward P/E

8.00

PEG ratio

8.00

Price/Sales (ttm)

2.40

Price/Book (mrq)

6.65

Enterprise Value/Revenue

3.32

Enterprise Value/EBITDA

8.22

Overview

Shares outstanding

2.03B

Float

2.02B

Shares short

23.42M

% Held by insiders

0.00%

% Held by institutions

0.78%

Average volume (10 days)

14.01M

Average volume (90 days)

Price summary

52-Week low

39.35

52-Week high

61.08

52-Week change

14.03%

Beta

0.44

50-Day moving average

52.73

200-Day moving average

48.30

Dividends and splits

Forward annual dividend rate

2.40

Forward annual dividend yield

0.04

Trailing annual dividend rate

2.40%

Trailing annual dividend yield

0.04

5-Year annual dividend yield

3.41

Payout ratio

0.60

Dividend date

November 01th, 2024

Ex-dividend date

October 04th, 2024

Last split factor

2:1

Last split date

August 07th, 2001

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-15.30%

Operating margin

18.48%

Operational effectiveness

Return on assets

6.07%

Return on equity

-31.33%

Income statement

Revenue (ttm)

23.41

Revenue per share (ttm)

23.41

Quarterly revenue growth (yoy)

-0.37

Gross profit (ttm)

34.31B

EBITDA

18.41B

Net income to common (ttm)

-7,257,999,872.00

Diluted EPS (ttm)

-3.58

Quarterly earnings growth (yoy)

-37.20%

Balance sheet

Total cash (mrq)

8.09B

Total cash per share (mrq)

3.99

Total debt (mrq)

51.44B

Total Debt/Equity (mrq)

299.05

Current ratio (mrq)

124.00%

Book value per share (mrq)

8.45

Cash flow

Cash flow statement

15.00B

Levered free cash flow (LFCF)

17.52B